We have expanded the quoting options on our website with the addition of Principal disability and the final expense, long-term care, cancer, critical illness and express issue life insurance plans issued by Mutual of Omaha. These can all be found by clicking on Illustrations from the menu after logging in. Look for additional enhancements to our website in the coming weeks.
Effective with life insurance approvals on or after June 1st, your eligible clients will no longer be automatically opted-in to the complimentary one-year Cancer Guardian benefit. Going forward, your clients will not be contact by Wamberg Genomic Advisors regarding Cancer Guardian. Instead, they will be required to sign up on the Cancer Guardian website at your prompting. To activate their complimentary Cancer Guardian participation, your clients will need to go to https://life.cancerguardian.com and click on ENROLL NOW in the upper right hand corner of the page. Be sure they select Agency Code 003 and enter your name as their agent on the enrollment page to confirm their eligibility. With this new format, you, as their insurance advisor, will be the only information source regarding their eligibility and the program’s benefits. | more
The Wamberg Genomic Advisors Cancer Guardian program is now live! The Cancer Guardian program is available to any proposed insured approved on or after March 1, 2018, for a life insurance policy through The Brokers Network and will be free of charge for the first year. In addition, your client’s spouse/companion and their dependent children under the age 26 are eligible to participate for a small fee.
Cancer Guardian gives your client access to leading comprehensive cancer genomic profiling at no additional charge in the unfortunate event they are diagnosed with cancer. The genomic profiling will identify the genetic makeup of the cancerous tumor and provide your client’s healthcare providers with additional information to aid them in creating a targeted plan of care. As one in four cancers are misdiagnosed, this genomic profiling could save your client’s life! | Cancer Guardian details